Suppr超能文献

重症监护患者中的血栓调节蛋白

Thrombomodulin in intensive care patients.

作者信息

Boldt J, Wollbrück T, Sonneborn S, Welters A, Hempelmann G

机构信息

Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen, Germany.

出版信息

Intensive Care Med. 1995 Aug;21(8):645-50. doi: 10.1007/BF01711542.

Abstract

OBJECTIVE

Changes of endothelial-related coagulation was studied in intensive care patients.

DESIGN

Descriptive, prospective.

SETTING

Clinical investigation, intensive care unit of an university hospital.

PATIENTS

40 consecutive critically ill patients with severe trauma (n = 20) or postoperative complications (n = 20) were studied. 14 patients suffered from sepsis, 12 patients suffered from acute renal failure.

INTERVENTIONS

12 patients with acute renal failure were continuously hemofiltrated. All patients were on continuous sedation (fentanyl and midazolam) and mechanical ventilation.

MEASUREMENTS

In addition to standard coagulation variables, thrombomodulin (TM), protein C and protein S as well as thrombin/antithrombin III (TAT) plasma concentrations were measured from arterial blood samples using enzyme-linked immuno-sorbent assays (ELISA). Measurements were carried out on the day of admission (trauma patients) or on the day of diagnosis of sepsis and during the next 4 days.

MAIN RESULTS

Throughout the entire investigation period, TM plasma concentrations in patients with sepsis (baseline: 90 +/- 25 micrograms/l, 4th day: 152 +/- 28 micrograms/l) were significantly higher than in non-septic patients (baseline: 60 +/- 29 micrograms/l, 4th day: 42 +/- 15 micrograms/l). 15 of the 40 patients died within or after the end of the investigation period. TM plasma concentrations of survivors were lower (maximum: 63 +/- 18 micrograms/l) than in the non-survivors (maximum: 159 +/- 22 micrograms/l) (p < 0.05). Hemofiltered patients showed higher TM plasma levels, which further increased during the hemofiltration procedure. Protein C and (free) protein S were without significant group differences. TAT plasma levels were elevated above normal in all patients (no group differences).

CONCLUSIONS

Besides plasmatic and platelet-related coagulation, endothelium-associated coagulation appears to be also important for maintenance of hemostasis. TM plasma concentrations were elevated in all our critically ill patients, particularly when sepsis was evident. This appears to be most likely due to endothelial membrane damage with increased release of membrane-bound TM into the circulating blood in these patients. The importance of the elevated plasma levels of circulating soluble TM on hemostasis in these patients is an ongoing debate and warrants further studies.

摘要

目的

研究重症监护患者内皮相关凝血的变化。

设计

描述性、前瞻性研究。

地点

大学医院重症监护病房的临床研究。

患者

对40例连续的重症患者进行研究,其中20例为严重创伤患者,20例为术后并发症患者。14例患者患有脓毒症,12例患者患有急性肾衰竭。

干预措施

12例急性肾衰竭患者接受持续血液滤过治疗。所有患者均接受持续镇静(芬太尼和咪达唑仑)及机械通气。

测量指标

除标准凝血指标外,采用酶联免疫吸附测定(ELISA)法从动脉血样本中检测血栓调节蛋白(TM)、蛋白C和蛋白S以及凝血酶/抗凝血酶III(TAT)的血浆浓度。测量在入院当天(创伤患者)或脓毒症诊断当天及随后4天进行。

主要结果

在整个研究期间,脓毒症患者的TM血浆浓度(基线:90±25微克/升,第4天:152±28微克/升)显著高于非脓毒症患者(基线:60±29微克/升,第4天:42±15微克/升)。40例患者中有15例在研究期间内或结束后死亡。幸存者的TM血浆浓度(最高:63±18微克/升)低于非幸存者(最高:159±22微克/升)(p<0.05)。接受血液滤过的患者TM血浆水平较高,且在血液滤过过程中进一步升高。蛋白C和(游离)蛋白S在各组间无显著差异。所有患者的TAT血浆水平均高于正常(无组间差异)。

结论

除血浆和血小板相关凝血外,内皮相关凝血似乎对维持止血也很重要。在我们所有的重症患者中,TM血浆浓度均升高,尤其是在脓毒症明显时。这似乎最有可能是由于这些患者内皮细胞膜受损,导致膜结合TM释放增加进入循环血液。循环中可溶性TM血浆水平升高对这些患者止血的重要性仍在争论中,值得进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验